药物对比
Insulin Degludec vs Troglitazone
Insulin Degludec 与 Troglitazone 治疗糖尿病的比较。Degludec 是长效胰岛素；Troglitazone 因肝毒性于 2000 年撤市。
此页面暂无可用的对比维度。
临床背景
This comparison arises when reviewing historical versus current diabetes treatments or inquiring about withdrawn TZDs like Troglitazone.
结论
Insulin Degludec is the appropriate current option since Troglitazone is discontinued due to hepatotoxicity risks.
全部药物对比